Kyrgyzstan has initiated its first national survey on antimicrobial resistance (AMR), an effort aimed at understanding and combating this pressing global health issue. The survey, supported by the World Health Organization (WHO), seeks to provide vital insights into AMR dynamics within the country, assess its impact on public health and the economy, and develop strategies to mitigate its spread.
AMR poses a threat by rendering conventional antibiotics less effective, thus jeopardizing essential medical treatments. Kyrgyzstan's proactive approach not only addresses local health concerns but also sets a global benchmark in the fight against AMR. The survey will evaluate the prevalence of AMR, focusing on its effects on human bloodstream bacterial infections, and will guide evidence-based policies and clinical protocols.
The launch event in Bishkek, held in June 2024, saw participation from Kyrgyzstan's ministers, members of parliament, development partners, foreign embassies, various ministries, healthcare workers, and WHO experts. The WHO's support was instrumental, providing over $300,000 in equipment and diagnostic tools. Additionally, extensive training was delivered to personnel from 40 hospitals and 3 central reference laboratories across Kyrgyzstan.
Dr. Liviu Vedrasco, WHO Representative to Kyrgyzstan, emphasized the importance of the initiative:
"Understanding the extent and impact of antimicrobial resistance is paramount for safeguarding public health and fostering sustainable healthcare systems. This initiative marks a pivotal moment in our collective efforts to combat this pressing global health threat."
The findings from this comprehensive survey are expected to inform national strategies to reduce AMR's adverse effects and improve patient care in Kyrgyzstan, while also contributing to global efforts to address this critical health challenge.
Follow Daryo's official Instagram and Twitter pages to keep current on world news.
Comments (0)